Analytical and Chemical Enhancements to Improve Efficacy and Accuracy of Therapeutic Oligonucleotides
See how top pharma players are addressing impure, unstable, and off-target oligos
Boosting the Efficacy of Safe, Scalable, & Precise Vaccines
Innovations in mRNA Technology, RNA Therapeutics, and Cancer Immunotherapy for 2024
.png)
Tumbler: A Highly Customizable Antibody Optimization Suite
On-demand presentation, presented by Michali Izhaky, Bioinformatics Scientist at Charles River
Leading Innovations in Fab, ScFv, & VHH Production and Engineering
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Advancing Immunotherapy: The Critical Role of GMP-Grade Cytokines in Cell Therapy
On-demand webinar presented by Ritwika Biswas, Field Application Scientist at Sino Biological
Optimizing Bispecific Antibody Production: From Identifying Optimal Pairings to Scale-up Processes
On-demand webinar presented by Dr Jiansheng Wu, Head of Protein Sciences and Vice President at WuXi Biologics
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Biomarkers & Precision Medicine
AtlaZ: Quantitative Live-Cell Analytics
Welcome to the next level of live-cell analytics.
Biomarkers & Precision Medicine
Bioanalytical Solutions for CAR-T and NK Cell Therapies
Synexa Life Sciences is a bioanalytical and biomarker services laboratory specializing in the development and validation of complex and custom designed assays with progression into clinical trial sample analysis.
Immuno-Oncology
Chromium X: the Most Flexible Way to Single Cell
Single cell analysis has been a revolutionary breakthrough in biology. Understanding cellular diversity has enabled significant insights into intracellular mechanisms and their applications to health and disease. But for many researchers, single cell has been out of reach due to technical, cost-per-cell, and scalability challenges.
Biomarkers & Precision Medicine
Hyperion XTi™ Imaging System
Uniquely designed for clinical research.
Biomarkers & Precision Medicine
Immune Cell-mediated Killing of A549 Cancer Target Cells in Real-time
Nanion Technologies GmbH, Munich. TUM, Munich
Biomarkers & Precision Medicine
Nanion: Cell Analytics Brochure
Next level live-cell kinetic and phenotypic assays.
Biomarkers & Precision Medicine
NeoGenomics: Connect With Us to Explore How Our Oncology Data and Expertise Can Help Your Team
Data-driven insights from the largest volume cancer-testing lab in the U.S.
Biomarkers & Precision Medicine
NeoGenomics: Transforming Care for Cancer Patients
Comprehensive service overview for pharmaceutical partners
Biomarkers & Precision Medicine
Rules Based Medicine: Human Services Catalog
Rules-Based Medicine (RBM), a Q2 Solutions Company, is a CLIA-certified immunoassay testing laboratory that solves complex drug development challenges with innovative biomarker services and products.
Biomarkers & Precision Medicine
Rules Based Medicine: Operational Procedures
Rules-Based Medicine (RBM), a Q2 Solutions Company, has spent over 20 years developing and optimizing multiplex immunoassays based on the Luminex xMAP® technology.
Biomarkers & Precision Medicine